AI Engines For more Details: Perplexity Kagi Labs You
Gram-Negative Infections: Aztreonam is particularly effective against gram-negative bacteria. It may be used to treat infections caused by organisms such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterobacter species, and Haemophilus influenzae.
Lower Respiratory Tract Infections: Aztreonam can be used to treat lower respiratory tract infections, including pneumonia, caused by susceptible gram-negative bacteria.
Urinary Tract Infections (UTIs): Aztreonam may be prescribed to treat UTIs caused by susceptible gram-negative bacteria.
Intra-Abdominal Infections: It may be used to treat intra-abdominal infections, such as peritonitis, caused by susceptible gram-negative bacteria.
Skin and Soft Tissue Infections: Aztreonam may be effective in treating skin and soft tissue infections caused by susceptible gram-negative bacteria.
Gynecological Infections: In some cases, aztreonam may be used to treat gynecological infections caused by susceptible gram-negative bacteria.
Sepsis: Aztreonam may be used as part of the treatment regimen for sepsis caused by susceptible gram-negative bacteria.
Cystic Fibrosis: Aztreonam inhalation solution (Cayston) is specifically approved for the management of respiratory infections in patients with cystic fibrosis caused by Pseudomonas aeruginosa.
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]
